Professor Erika Lietzan has been awarded a second Thomas Edison Innovation Fellowship from the Center for the Protection of Intellectual Property at George Mason University’s Antonin Scalia Law School.
The Thomas Edison Fellowship is a year-long non-resident fellowship program that brings together a group of scholars to develop research papers on patent law and policy. The program consists of a series of invitation-only conferences over the course of a year in which the fellows study and discuss a structured curriculum, engage in roundtable discussions with expert senior scholars and industry representatives, and share and collaborate on their research and early drafts. The fellowship culminates in the production of substantial academic research papers published in law journals or peer-reviewed academic journals.
Professor Lietzan focuses on issues at the intersection of intellectual property law and FDA regulation of drugs and medical devices. She received a fellowship for the 2016-2017 academic year, and this project considers the misalignment between premarket research and development for approval of new drugs, on one hand, and post-approval effective patent life and data exclusivity, on the other hand. She has just been awarded another fellowship for the 2017-2018 academic year.